1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
30.49%
Revenue growth under 50% of FSLR's 63.37%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
15.26%
Gross profit growth under 50% of FSLR's 104.14%. Michael Burry would be concerned about a severe competitive disadvantage.
231.50%
EBIT growth below 50% of FSLR's 4289.94%. Michael Burry would suspect deeper competitive or cost structure issues.
233.84%
Operating income growth under 50% of FSLR's 4289.94%. Michael Burry would be concerned about deeper cost or sales issues.
127.15%
Net income growth under 50% of FSLR's 1852.83%. Michael Burry would suspect the firm is falling well behind a key competitor.
118.18%
EPS growth under 50% of FSLR's 1660.00%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
122.22%
Diluted EPS growth under 50% of FSLR's 2075.00%. Michael Burry would worry about an eroding competitive position or excessive dilution.
1.12%
Share count expansion well above FSLR's 0.05%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
6.90%
Slight or no buyback while FSLR is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
75.45%
Positive OCF growth while FSLR is negative. John Neff would see this as a clear operational advantage vs. the competitor.
52.35%
Positive FCF growth while FSLR is negative. John Neff would see a strong competitive edge in net cash generation.
No Data
No Data available this quarter, please select a different quarter.
2.55%
5Y revenue/share CAGR under 50% of FSLR's 55.38%. Michael Burry would suspect a significant competitive gap or product weakness.
-29.64%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
-129.65%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-212.65%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
No Data
No Data available this quarter, please select a different quarter.
18.49%
Positive 5Y CAGR while FSLR is negative. John Neff might view this as a strong mid-term relative advantage.
106.47%
Positive short-term CAGR while FSLR is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
-26.07%
Negative 5Y equity/share growth while FSLR is at 63.75%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-11.49%
Negative 3Y equity/share growth while FSLR is at 2.59%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
14.73%
AR growth well above FSLR's 2.35%. Michael Burry fears inflated revenue or higher default risk in the near future.
-14.97%
Inventory is declining while FSLR stands at 23.03%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
2.00%
Positive asset growth while FSLR is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
2.08%
75-90% of FSLR's 2.63%. Bill Ackman advocates improvements in profitability or buybacks to keep pace in net worth growth.
0.25%
Debt shrinking faster vs. FSLR's 12.11%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
4.28%
R&D dropping or stable vs. FSLR's 15.11%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
-4.34%
We cut SG&A while FSLR invests at 15.37%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.